HOLLISTON — Medical instruments maker Harvard Bioscience Inc. said it has acquired Coulbourn Instruments, a private company that makes lab equipment for assessing learning and memory.
Harvard Bioscience did not disclose financial details.
It estimates the total market for the instruments Coulbourn produces is between $40 million and $50 million. It expects the company to add about $4 million in annual revenue.
Harvard Bioscience shares rose 2 cents to $3.43.